Clinical Trial Update: Copanlisib Pharmacodynamic Study [Phase 1]

View source ↗

Summary

Phase 1 pharmacodynamic study of copanlisib in non-Hodgkin lymphoma has completed. The document indicates this early-stage trial produced pharmacodynamic data.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-hodgkin Lymphoma

Drugs mentioned

• Copanlisib (copanlisib)

Snippet

Sponsor: Bayer | Conditions: Non Hodgkin Lymphoma | Phase 1 | Status: COMPLETED